Cargando…
The Effect of 12 Weeks of β-Hydroxy-β-Methyl-Butyrate Supplementation after Liver Transplantation: A Pilot Randomized Controlled Study
Sarcopenia is a frequent complication in liver transplant (LT) recipients. β-hydroxy-β-methyl-butyrate (HMB) has the potential to increase muscle-performance and tropism. Our study aims at evaluating the effect on muscle mass and functioning, and the safety of 12 weeks of HMB supplementation in pati...
Autores principales: | Lattanzi, Barbara, Giusto, Michela, Albanese, Carlina, Mennini, Gianluca, D’Ambrosio, Daria, Farcomeni, Alessio, Ginanni Corradini, Stefano, Rossi, Massimo, Merli, Manuela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769827/ https://www.ncbi.nlm.nih.gov/pubmed/31546969 http://dx.doi.org/10.3390/nu11092259 |
Ejemplares similares
-
Weight Gain and De Novo Metabolic Disorders after Liver Transplantation
por: Lattanzi, Barbara, et al.
Publicado: (2019) -
Adult 10-year survivors after liver transplantation: a single-institution experience over 40 years
por: Lai, Quirino, et al.
Publicado: (2023) -
Donor Small-Droplet Macrovesicular Steatosis Affects Liver Transplant Outcome in HCV-Negative Recipients
por: Ferri, Flaminia, et al.
Publicado: (2019) -
The Spread of Multi Drug Resistant Infections Is Leading to an Increase in the Empirical Antibiotic Treatment Failure in Cirrhosis: A Prospective Survey
por: Merli, Manuela, et al.
Publicado: (2015) -
An umbrella review of systematic reviews of β‐hydroxy‐β‐methyl butyrate supplementation in ageing and clinical practice
por: Phillips, Stuart M., et al.
Publicado: (2022)